Skip to main content
animation of illustrated demodex mites holding party favors in front of an illustrated eye
animation of illustrated demodex mites holding party favors in front of an illustrated eye
animation of illustrated demodex mites holding party favors in front of an illustrated eye

Images are character representations of Demodex mites.

DEMODEX BLEPHARITIS (DB) AND YOU

Take Our DB Quiz

Whether you’re newly diagnosed or have been dealing with Demodex blepharitis (DB) for years, this quiz can offer you insights into how you have been managing the disease. It can better prepare you to have a more informed and productive discussion with your doctor.

(*Fields marked with asterisks are required.)

Which of these symptoms of Demodex blepharitis (DB) are you currently experiencing?1–3

(Check all that apply.)
Are you currently being treated for Demodex blepharitis (DB)?
What have you used to treat your Demodex blepharitis (DB)?

(Check all that apply.)
Have you made any lifestyle or routine changes to manage or alleviate your DB symptoms?
How often do you visit an eye care professional?
Would you be interested in a prescription treatment for DB?
Illustrated person icon standing behind microphone

LIVING WITH DB?

Tell us about your experience and inspire others.

JOIN THE CONVERSATION
Illustrated demodex mite peers around a bottle of XDEMVY next to party favors in a puddle of liquid

One drop per eye, twice a day (~12 hours apart), for 6 weeks.

TREATMENT WITH XDEMVY

You can address the root cause of DB.

LEARN MORE
illustrated demodex mite paralyzed along with text that reads party’s over
References

References: 1. Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom (Aukl). 2018;10:57–63. 2. Rhee MK, Yeu E, Barnett M, et al. Demodex blepharitis: a comprehensive review of the disease, current management, and emerging therapies. Eye Contact Lens. 2023;49(8):311-318. 3. Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153–1164. 

References: 1. Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom (Aukl). 2018;10:57–63. 2. Rhee MK, Yeu E, Barnett M, et al. Demodex blepharitis: a comprehensive review of the disease, current management, and emerging therapies. Eye Contact Lens. 2023;49(8):311-318. 3. Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153–1164. 

Footer address

15440 Laguna Canyon Road, Ste 160
Irvine, CA 92618

©2024 Tarsus Pharmaceuticals, Inc.  
Tarsus, the Tarsus logo, and certain other trademarks herein are trademarks of Tarsus Pharmaceuticals, Inc.   
US--2400059 3/24

You are leaving the XDEMVY® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY® patient website and going to the healthcare professional website.

You are leaving the XDEMVY® patient website.

Are you a US healthcare professional?

Click YES to leave this site, or click NO to return to the XDEMVY patient site.

YES NO